Results, forecasts and guidance revisions from Japan's listed companies, in English.
LaSalle Logiport REIT is selling four logistics buildings in deals closing between this month and September 2027, and used the same disclosure day to raise its distribution forecast for the period to next February by a third to ¥4,282 per unit, crediting the sale gains and a unit buyback that shrinks its outstanding count to about 1.6 million units.
Cosel says demand for AI-related semiconductor manufacturing equipment helped its quarterly orders jump 155%, prompting Japan's power-supply maker to raise full-year operating-profit guidance by 72% to ¥2.3bn just three months after its last forecast.
Overseas wholesale orders for Hobonichi's 2027 planner more than doubled from a year earlier, and that order intake, not confirmed retail sell-through, is why the stationery maker raised its full-year sales and profit forecasts on September 17.
Slow price pass-through on thick steel plate has pushed Chubu Steel Plate to guide for an ¥800mn first-half operating loss and cut full-year operating-profit guidance by 75% to ¥300mn.
Eternal Hospitality Group missed its own profit guidance for the year to July 2026, booked a ¥391mn impairment tied to closing four of seven Shanghai stores, and has now halved next year's operating-profit target while domestic same-store sales keep outperforming.
Mercari's net profit rose 36% to ¥35.4bn in the year to June 2026, as marketplace transactions topped ¥1.29tn on renewed double-digit growth, its Mercard credit card program passed 6 million cards issued, and its long-breakeven US business posted its best result yet, even though the company again paid no dividend.
JUSTPLANNING is selling all three of its solar plants to Tokyu Fudosan and booking a ¥293mn gain that lifts its net-profit forecast 39.6% to ¥670mn, even though the sale itself trims sales and operating profit and ends the company's entire solar segment from October 1.
Kringle Pharma raised its annual sales guidance and narrowed its projected loss for the year to September 2026 after signing an exclusive Japan licensing deal with Maruishi Pharmaceutical for an experimental vocal-fold-scar treatment, under which it will record a ¥100 million upfront fee as revenue this fiscal year, with roughly half of the improved loss forecast coming instead from ¥108 million of development spending that shifted into next year.
Tera Probe's preliminary August sales rose 50% year on year to ¥5.52bn, slower than July's 62.6% jump, while its cumulative eight-month sales climbed 47% to ¥38.43bn, the fastest year-to-date rate the chip tester has posted this year; the company flagged the figures as preliminary and subject to revision.
Digital Holdings supplied about 5 of the 7.5% sales growth Hakuhodo DY reported for the quarter, leaving organic growth under 3%, while management said AI is already shortening how long North American clients need consulting help.
Foreign-visitor spending at Daimaru Matsuzakaya fell in August even as each shopper spent more, then swung to a 37% year-on-year surge in the first two weeks of September, while the Osaka Umeda store keeps dragging on department-store totals and PARCO's shopping centres post an 8.6% gain.
ASKUL's quarterly sales fell 8.2% and operating profit turned into a ¥418 million loss as the company keeps rebuilding from an October 2025 ransomware attack, yet it has not touched its full-year forecast of ¥7 billion in operating profit, a target that now depends on a sharp turnaround over the next three quarters.
Smaregi's operating profit rose 73.3% in the quarter through July as recurring subscription revenue and newly in-housed cashless-payment processing pushed its margin to 28.5%, even though the company left its full-year sales and profit targets unchanged.
Six-month sales at the Sabae eyewear group rose 14.8% to \u00a510.26bn as price increases and inbound tourist demand drove a 20% jump at its main brand, even as the group's second brand grew just 4.5% on slower overseas wholesale.
SanBio's cell therapy for chronic traumatic brain injury, known by its development code SB623, cleared its final approval hurdle and reached the market in 2026 with a ¥72mn price tag, yet the company's latest results show no product revenue, a shrinking cash pile, and a 20.29% cut to capital to offset accumulated losses.
TOKYO BASE's first-half revenue jumped 21.1% largely on tax-free tourist spending, which supplied 72% of the increase in domestic store sales, while like-for-like sales slipped at UNITED TOKYO, PUBLIC TOKYO and CITY, the company's own original formats.
Placement and job-fair revenue jumped at recruiting firm Gakujo while its core job board barely grew, because Japanese graduates now hold 1.46 informal offers each on average, up from 1.26 a year ago, and are declining the ones they don't want later than before.
SAMCO, the Kyoto semiconductor-equipment maker, closed the year to July 2026 with sales up 15.6% to ¥10.8bn and a year-end order backlog that more than doubled to ¥11.46bn, while compound-semiconductor sales grew 45.9% and sales linked to plain silicon wafers dropped by more than half.
Mori Hills REIT kept its distribution at ¥3,100 per unit even as net income fell 5.2%, covering the shortfall with a reserve drawdown and a ¥1.257bn gain from selling part of its Laforet Harajuku land stake, a pattern management plans to repeat for two more periods.
Kumiai Chemical now expects full-year sales of ¥175.0bn, up 8% from its December guidance, but has cut operating profit guidance 62.5% to ¥2.7bn after generic rivals crushed prices for one of its export herbicides and forced an inventory writedown, even as equity-method gains and yen-driven forex gains cushioned the ordinary-profit line and the dividend forecast stayed at ¥24 a share.
Half-year net profit at Sekisui House rose 23% to ¥125.1bn on strong urban-redevelopment sales and property disposals to Sekisui House REIT Investment Corporation, even as its international segment, mostly US operations, saw operating profit collapse 93% to about ¥1.0bn amid American buyer hesitancy and heavier sales incentives.
H.I.S. swung to a ¥4.99bn net loss for the nine months through July after a ¥5.94bn charge to terminate a land lease at its Guam hotel, even as underlying travel demand held up: record inbound arrivals offset a weak yen and high fuel surcharges that kept outbound Japanese travel at only 74.2% of its 2019 level, and the company cut its interim dividend to zero while holding its full-year loss forecast steady.
ACCESS narrowed its first-half net loss to ¥588mn and grew revenue 16.8% almost entirely on one carryover network contract, yet its own filing still flags going-concern doubt and confirms the Tokyo Stock Exchange's internal-control review, which could end in delisting, remains open a year after its Special Attention designation.
A more-than-doubled quarterly net loss and a lost UK debris-removal tender didn't stop Astroscale from lifting cash to ¥34.95bn, up from ¥10.02bn, after a ¥30.6bn bond-and-share raise, with full-year loss guidance left unchanged.